BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $206,990 | -21.2% | 6,188 | +0.7% | 0.00% | -33.3% |
Q1 2024 | $262,711 | -0.2% | 6,147 | -9.7% | 0.00% | -25.0% |
Q4 2023 | $263,313 | -37.1% | 6,811 | -38.6% | 0.00% | -33.3% |
Q3 2023 | $418,355 | -81.1% | 11,085 | -77.1% | 0.01% | -81.8% |
Q2 2023 | $2,208,930 | +333.3% | 48,484 | +285.7% | 0.03% | +312.5% |
Q1 2023 | $509,817 | -26.6% | 12,569 | -7.7% | 0.01% | -33.3% |
Q4 2022 | $694,276 | +0.2% | 13,621 | +5.9% | 0.01% | -7.7% |
Q3 2022 | $693,000 | -16.1% | 12,859 | +0.0% | 0.01% | -13.3% |
Q2 2022 | $826,000 | -16.7% | 12,854 | +0.5% | 0.02% | 0.0% |
Q1 2022 | $992,000 | -9.0% | 12,790 | +0.8% | 0.02% | -11.8% |
Q4 2021 | $1,090,000 | +4.9% | 12,693 | -1.8% | 0.02% | -5.6% |
Q3 2021 | $1,039,000 | +0.2% | 12,920 | +0.3% | 0.02% | 0.0% |
Q2 2021 | $1,037,000 | -100.0% | 12,884 | -58.3% | 0.02% | -21.7% |
Q1 2021 | $2,602,680,000 | +246365.9% | 30,860 | +134.5% | 0.02% | 0.0% |
Q4 2020 | $1,056,000 | -12.4% | 13,160 | -12.2% | 0.02% | -23.3% |
Q3 2020 | $1,205,000 | -3.1% | 14,990 | +3.7% | 0.03% | -14.3% |
Q2 2020 | $1,244,000 | +8.7% | 14,452 | +2.5% | 0.04% | -16.7% |
Q1 2020 | $1,144,000 | -9.4% | 14,099 | -6.6% | 0.04% | +13.5% |
Q4 2019 | $1,262,000 | -3.0% | 15,093 | +1.4% | 0.04% | -15.9% |
Q3 2019 | $1,301,000 | +14.9% | 14,879 | +7.6% | 0.04% | +4.8% |
Q2 2019 | $1,132,000 | -2.8% | 13,833 | -3.5% | 0.04% | -14.3% |
Q1 2019 | $1,165,000 | +25.7% | 14,334 | +1.8% | 0.05% | +8.9% |
Q4 2018 | $927,000 | +67.3% | 14,086 | +95.9% | 0.04% | +73.1% |
Q3 2018 | $554,000 | +100.7% | 7,191 | +92.6% | 0.03% | +62.5% |
Q2 2018 | $276,000 | +60.5% | 3,733 | +40.9% | 0.02% | +33.3% |
Q1 2018 | $172,000 | +0.6% | 2,649 | 0.0% | 0.01% | -7.7% |
Q4 2017 | $171,000 | -2.3% | 2,649 | -5.3% | 0.01% | -27.8% |
Q3 2017 | $175,000 | -75.0% | 2,798 | -75.8% | 0.02% | -77.2% |
Q2 2017 | $699,000 | -6.7% | 11,559 | -20.0% | 0.08% | -30.1% |
Q1 2017 | $749,000 | +1169.5% | 14,444 | +969.9% | 0.11% | +318.5% |
Q4 2016 | $59,000 | – | 1,350 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |